None
Quote | Ohr Pharmaceutical Inc. (NASDAQ:OHRP)
Last: | $ |
---|---|
Change Percent: | 30.19% |
Open: | $4.10 |
Close: | $5.39 |
High: | $5.75 |
Low: | $3.98 |
Volume: | 1,579,642 |
Last Trade Date Time: | 07/12/2019 04:56:45 pm |
News | Ohr Pharmaceutical Inc. (NASDAQ:OHRP)
Company expects to initiate trading on NASDAQ Under Ticker Symbol “NBSE” effective July 15, 2019 Company completes previously announced financing of approximately $9 million immediately prior to closing of the merger Greenlight Capital agrees to purchase ~9% of Ne...
NEW YORK, July 10, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (“Ohr”) (Nasdaq: OHRP) today announced that all proposals related to its proposed merger with NeuBase Therapeutics, Inc. (“NeuBase”) were approved by Ohr’s stockholders at a special meeti...
Message Board Posts | Ohr Pharmaceutical Inc. (NASDAQ:OHRP)
Subject | By | Source | When |
---|---|---|---|
NeuBase Therapeutics Announces Addition of Industry Pioneer Dr. | realfast95 | investorshub | 07/30/2019 5:05:36 PM |
NBSE - other filers today including the CEO | realfast95 | investorshub | 07/23/2019 5:11:40 PM |
Carnegie Mellon University 13G | realfast95 | investorshub | 07/22/2019 11:18:27 PM |
$OHRP now NBSE | realfast95 | investorshub | 07/17/2019 4:00:23 PM |
$OHRP Daily Chart | Golden Cross | investorshub | 07/12/2019 10:42:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Ohr Pharmaceutical Inc. Company Name:
OHRP Stock Symbol:
NASDAQ Market:
Ohr Pharmaceutical Inc. Website:
Company expects to initiate trading on NASDAQ Under Ticker Symbol “NBSE” effective July 15, 2019 Company completes previously announced financing of approximately $9 million immediately prior to closing of the merger Greenlight Capital agrees to purchase ~9% of Ne...
NEW YORK, July 10, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (“Ohr”) (Nasdaq: OHRP) today announced that all proposals related to its proposed merger with NeuBase Therapeutics, Inc. (“NeuBase”) were approved by Ohr’s stockholders at a special meeti...
-- Of the Votes Received to Date, More than 99% Are Voting in Favor of the Merger Proposal -- More Votes Are Needed to Reach 50% of the Outstanding Shares to Go Forward with the Special Meeting -- Every Vote Is Important to Avoid Delay in Completion of the Merger NEW YORK, July 03, ...